13FBIOCRYST PHARMACEUTICALS INC (BCRX)
6 tracked managers currently hold BCRX on their latest filing. Change is versus that manager’s previous filing. Reported as of quarter end, filed up to ~45 days later, not live positions.
Sort: Size Weight change
Sorted by reported value on the latest filing.
| Manager | Period | Change | Value | Weight | Prev weight | Shares | Δ shares |
|---|---|---|---|---|---|---|---|
| TWO SIGMA INVESTMENTS, LP | Q2 2026 | ADD | $67.8M | 0.1 % | 0.1 % | 6,775,349 | +382,721 |
| MILLENNIUM MANAGEMENT LLC | Q2 2026 | ADD | $33.9M | 0.0 % | 0.0 % | 3,394,729 | +3,207,008 |
| CITADEL ADVISORS LLC | Q2 2026 | ADD | $17.6M | 0.0 % | 0.0 % | 1,759,160 | +740,417 |
| Bridgewater Associates, LP | Q2 2026 | TRIM | $4.9M | 0.0 % | 0.0 % | 491,057 | -146,997 |
| D. E. Shaw & Co., Inc. | Q2 2026 | ADD | $4.1M | 0.0 % | 0.0 % | 408,529 | +106,428 |
| Point72 Asset Management, L.P. | Q2 2026 | NEW | $2.6M | 0.0 % | — | 260,917 | NEW |